Choose the experimental features you want to try

This document is an excerpt from the EUR-Lex website

Document 52024XC04646

Summary of European Union decisions on marketing authorisations in respect of medicinal products from 1 June 2024 to 30 June 2024 (Published pursuant to Article 13 or Article 38 of Regulation (EC) No 726/2004 of the European Parliament and of the Council or Article 5 of Regulation (EU) 2019/6 of the European Parliament and of the Council)

PUB/2024/703

OJ C, C/2024/4646, 31.7.2024, ELI: http://data.europa.eu/eli/C/2024/4646/oj (BG, ES, CS, DA, DE, ET, EL, EN, FR, GA, HR, IT, LV, LT, HU, MT, NL, PL, PT, RO, SK, SL, FI, SV)

ELI: http://data.europa.eu/eli/C/2024/4646/oj

European flag

Official Journal
of the European Union

EN

C series


C/2024/4646

31.7.2024

Summary of European Union decisions on marketing authorisations in respect of medicinal products from 1 June 2024 to 30 June 2024

(Published pursuant to Article 13 or Article 38 of Regulation (EC) No 726/2004 of the European Parliament and of the Council  (1) or Article 5 of Regulation (EU) 2019/6 of the European Parliament and of the Council  (2) )

(C/2024/4646)

Issuing of a marketing authorisation (Article 13 of Regulation (EC) No 726/2004 of the European Parliament and of the Council): Accepted

Date of the decision

Name of the medicinal product

INN (International Non-Proprietary Name)

Holder of the marketing authorisation

Number of the entry in the Community Register

Pharmaceutical form

ATC code (Anatomical Therapeutic Chemical Code)

Date of notification

3.6.2024

Fluenz

Influenza vaccine (live attenuated, nasal)

AstraZeneca AB

151 85 Södertälje, Sverige

EU/1/24/1816

Nasal spray, suspension

J07BB03

4.6.2024

17.6.2024

ALTUVOCT

efanesoctocog alfa

Swedish Orphan Biovitrum AB (publ)

112 76 Stockholm, Sverige

EU/1/24/1824

Powder and solvent for solution for injection

B02BD02

18.6.2024

17.6.2024

Sirturo

bedaquiline

Janssen-Cilag International NV

Turnhoutseweg 30, 2340 Beerse, België

EU/1/13/901

Tablet

J04AK05

18.6.2024

17.6.2024

Truqap

capivasertib

AstraZeneca AB

151 85 Södertälje, Sverige

EU/1/24/1820

Film-coated tablet

L01EX27

18.6.2024

20.6.2024

FRUZAQLA

fruquintinib

Takeda Pharmaceuticals International AG Ireland Branch

Block 2 Miesian Plaza, 50-58 Baggot Street Lower, Dublin 2, D02 HW68, Ireland

EU/1/24/1827

Capsule, hard

L01EK

25.6.2024

20.6.2024

Tofidence

tocilizumab

Biogen Netherlands B.V.

Prins Mauritslaan 13, 1171 LP Badhoevedorp, Nederland

EU/1/24/1825

Concentrate for solution for infusion

L04AC07

21.6.2024

20.6.2024

Wezenla

Ustekinumab

Amgen Technology (Ireland) UC

Pottery Road, Dun Laoghaire, Co. Dublin, Ireland

EU/1/24/1823

Concentrate for solution for infusion

Solution for injection

Solution for injection in a pre-filled syringe

L04AC05

22.6.2024

27.6.2024

Eribulin Baxter

eribulin

Baxter Holding B.V.

Kobaltweg 49, 3542 CE Utrecht, Nederland

EU/1/24/1819

Solution for injection

L01XX41

1.7.2024

27.6.2024

JERAYGO

aprocitentan

Idorsia Pharmaceuticals Deutschland GmbH

Marie-Curie-Strasse 8, 79539 Loerrach, Deutschland

EU/1/24/1818

Film-coated tablet

C02KN01

28.6.2024

27.6.2024

Obgemsa

Vibegron

PIERRE FABRE MEDICAMENT

Les Cauquillous, 81500 Lavaur, France

EU/1/24/1822

Film-coated tablet

G04BD15

28.6.2024

27.6.2024

Rybrevant

amivantamab

Janssen-Cilag International NV

Turnhoutseweg 30, 2340 Beerse, België

EU/1/21/1594

Concentrate for solution for infusion

L01FX18

28.6.2024

28.6.2024

IXCHIQ

Chikungunya vaccine (live)

Valneva Austria GmbH

Campus Vienna Biocenter 3, 1030 Wien, Österreich

EU/1/24/1828

Powder and solvent for solution for injection

Pending

28.6.2024

Modification of a marketing authorisation (Article 13 of Regulation (EC) No 726/2004 of the European Parliament and of the Council): Accepted

Date of the decision

Name of the medicinal product

Holder of the marketing authorisation

Number of the entry in the Community Register

Date of notification

6.6.2024

Alecensa

Roche Registration GmbH

Emil-Barell-Strasse 1, 79639 Grenzach-Wyhlen, Deutschland

EU/1/16/1169

7.6.2024

6.6.2024

Cinqaero

Teva B.V.

Swensweg 5, 2031 GA Haarlem, Nederland

EU/1/16/1125

11.6.2024

6.6.2024

Efavirenz/Emtricitabine/Tenofovir disoproxil Krka

KRKA d d., Novo mesto

Šmarješka cesta 6, 8501 Novo mesto, Slovenija

EU/1/17/1263

17.6.2024

6.6.2024

Fasenra

AstraZeneca AB

151 85 Södertälje, Sverige

EU/1/17/1252

7.6.2024

6.6.2024

Lymphoseek

Navidea Biopharmaceuticals Europe Ltd.

Kilminion South, Ballinroad, Dungarvan, Co. Waterford, X35 WP70, Ireland

EU/1/14/955

7.6.2024

6.6.2024

Pedmarqsi

Norgine B.V.

Antonio Vivaldistraat 150, 1083 HP Amsterdam, Nederland

EU/1/23/1734

7.6.2024

6.6.2024

Ritonavir Mylan

Mylan Pharmaceuticals Limited

Damastown Industrial Park, Mulhuddart, Dublin 15, DUBLIN, Ireland

EU/1/17/1242

7.6.2024

6.6.2024

Suliqua

Sanofi Winthrop Industrie

82 avenue Raspail, 94250 Gentilly, France

EU/1/16/1157

7.6.2024

6.6.2024

Sunlenca

Gilead Sciences Ireland UC

Carrigtohill, County Cork, T45 DP77, Ireland

EU/1/22/1671

7.6.2024

6.6.2024

Synflorix

GlaxoSmithKline Biologicals S.A.

rue de l'Institut 89, 1330 Rixensart, Belgique

EU/1/09/508

10.6.2024

6.6.2024

Tepmetko

Merck Europe B.V.

Gustav Mahlerplein 102, 1082 MA Amsterdam, Nederland

EU/1/21/1596

10.6.2024

6.6.2024

Twynsta

Boehringer Ingelheim International GmbH

Binger Straße 173, 55216 Ingelheim am Rhein, Deutschland

EU/1/10/648

17.6.2024

6.6.2024

Veltassa

Vifor Fresenius Medical Care Renal Pharma France

100-101 terrasse Boieldieu, Tour Franklin La Défense 8, 92042 Paris la Défense Cedex, France

EU/1/17/1179

7.6.2024

10.6.2024

AMGLIDIA

AMMTeK

8 rue campagne première, 75014 Paris, France

EU/1/18/1279

12.6.2024

10.6.2024

Ozempic

Novo Nordisk A/S

Novo Allé, 2880 Bagsvaerd, Danmark

EU/1/17/1251

11.6.2024

10.6.2024

Respreeza

CSL Behring GmbH

Emil-von-Behring-Straße 76, 35041 Marburg, Deutschland

EU/1/15/1006

26.6.2024

10.6.2024

Wegovy

Novo Nordisk A/S

Novo Allé, 2880 Bagsvaerd, Danmark

EU/1/21/1608

11.6.2024

13.6.2024

Atazanavir Viatris

Mylan Pharmaceuticals Limited

Damastown Industrial Park, Mulhuddart, Dublin 15, DUBLIN, Ireland

EU/1/16/1091

14.6.2024

13.6.2024

Darunavir Viatris

Mylan Pharmaceuticals Limited

Damastown Industrial Park, Mulhuddart, Dublin 15, DUBLIN, Ireland

EU/1/16/1140

14.6.2024

13.6.2024

Inbrija

Acorda Therapeutics Ireland Limited

10 Earlsfort Terrace, Dublin 2, D02 T380, Ireland

EU/1/19/1390

14.6.2024

13.6.2024

Lopinavir/Ritonavir Viatris

Mylan Pharmaceuticals Limited

Damastown Industrial Park, Mulhuddart, Dublin 15, DUBLIN, Ireland

EU/1/15/1067

14.6.2024

13.6.2024

Ritonavir Viatris

Mylan Pharmaceuticals Limited

Damastown Industrial Park, Mulhuddart, Dublin 15, DUBLIN, Ireland

EU/1/17/1242

14.6.2024

13.6.2024

TALVEY

Janssen-Cilag International NV

Turnhoutseweg 30, 2340 Beerse, België

EU/1/23/1748

14.6.2024

13.6.2024

TECVAYLI

Janssen-Cilag International NV

Turnhoutseweg 30, 2340 Beerse, België

EU/1/22/1675

14.6.2024

13.6.2024

Telmisartan Actavis

Actavis Group PTC ehf.

Dalshraun 1, 220 Hafnarfjörður, Íceland

EU/1/10/639

14.6.2024

17.6.2024

Eviplera

Gilead Sciences Ireland UC

Carrigtohill, County Cork, T45 DP77, Ireland

EU/1/11/737

18.6.2024

17.6.2024

Forxiga

AstraZeneca AB

151 85 Södertälje, Sverige

EU/1/12/795

18.6.2024

17.6.2024

Galafold

Amicus Therapeutics Europe Limited

Block 1, Blanchardstown Corporate Park, Ballycoolin Road, Blanchardstown, Dublin D15 AKK1, Ireland

EU/1/15/1082

19.6.2024

17.6.2024

Giotrif

Boehringer Ingelheim International GmbH

Binger Straße 173, 55216 Ingelheim am Rhein, Deutschland

EU/1/13/879

18.6.2024

17.6.2024

Givlaari

Alnylam Netherlands B.V.

Antonio Vivaldistraat 150, 1083 HP Amsterdam, Nederland

EU/1/20/1428

18.6.2024

17.6.2024

Kinpeygo

STADA Arzneimittel AG

Stadastraße 2-18, 61118 Bad Vilbel, Deutschland

EU/1/22/1657

20.6.2024

17.6.2024

Mektovi

Pierre Fabre Médicament

Les Cauquillous, 81500 Lavaur, France

EU/1/18/1315

18.6.2024

17.6.2024

Pioglitazone Actavis

Actavis Group PTC ehf.

Dalshraun 1, 220 Hafnarfjörður, Íceland

EU/1/12/755

18.6.2024

17.6.2024

Rasagiline Viatris

Mylan Pharmaceuticals Limited

Damastown Industrial Park, Mulhuddart, Dublin 15, DUBLIN, Ireland

EU/1/16/1090

18.6.2024

17.6.2024

Renagel

Sanofi B.V.

Paasheuvelweg 25, 1105 BP Amsterdam, Nederland

EU/1/99/123

19.6.2024

17.6.2024

Verzenios

Eli Lilly Nederland B.V.

Papendorpseweg 83, 3528 BJ Utrecht, Nederland

EU/1/18/1307

18.6.2024

17.6.2024

Vfend

Pfizer Europe MA EEIG

Boulevard de la Plaine 17, 1050 Bruxelles, Belgique/ Pleinlaan 17, 1050 Brussel, België

EU/1/02/212

18.6.2024

17.6.2024

Xultophy

Novo Nordisk A/S

Novo Allé, 2880 Bagsvaerd, Danmark

EU/1/14/947

19.6.2024

17.6.2024

Yentreve

Eli Lilly Nederland B.V.

Papendorpseweg 83, 3528 BJ Utrecht, Nederland

EU/1/04/280

18.6.2024

17.6.2024

Zometa

Phoenix Labs Unlimited Company

Suite 12, Bunkilla Plaza, Bracetown Business Park, Clonee, County Meath, Ireland

EU/1/01/176

18.6.2024

20.6.2024

Abecma

Bristol-Myers Squibb Pharma EEIG

Plaza 254, Blanchardstown Corporate Park 2, D15 T867, Dublin 15, Ireland

EU/1/21/1539

26.6.2024

20.6.2024

Abiraterone Mylan

Mylan Ireland Limited

Unit 35/36 Grange Parade, Baldoyle Industrial Estate, Dublin 13, Ireland

EU/1/21/1571

21.6.2024

20.6.2024

Bridion

Merck Sharp & Dohme B.V.

Waarderweg 39, 2031 BN Haarlem, Nederland

EU/1/08/466

24.6.2024

20.6.2024

Cinacalcet Accordpharma

Accord Healthcare S.L.U.

World Trade Center, Moll de Barcelona s/n, Edifici Est, 6a planta, 08039 Barcelona, España

EU/1/20/1429

21.6.2024

20.6.2024

CONTROLOC Control

Takeda GmbH

Byk-Gulden-Straße 2, 78467 Konstanz, Deutschland

EU/1/09/515

25.6.2024

20.6.2024

Cymbalta

Eli Lilly Nederland B.V.

Papendorpseweg 83, 3528 BJ Utrecht, Nederland

EU/1/04/296

25.6.2024

20.6.2024

Duloxetine Lilly

Eli Lilly Nederland B.V.

Papendorpseweg 83, 3528 BJ Utrecht, Nederland

EU/1/14/972

24.6.2024

20.6.2024

Ifirmacombi

KRKA d d., Novo mesto

Šmarješka cesta 6, 8501 Novo mesto, Slovenija

EU/1/11/673

26.6.2024

20.6.2024

Kesimpta

Novartis Ireland Limited

Vista Building, Elm Park, Merrion Road, Ballsbridge, Dublin 4, Ireland

EU/1/21/1532

21.6.2024

20.6.2024

Livmarli

Mirum Pharmaceuticals International B.V.

Kingsfordweg 151, 1043 GR Amsterdam, Noord-Holland, Nederland

EU/1/22/1704

21.6.2024

20.6.2024

Ocrevus

Roche Registration GmbH

Emil-Barell-Strasse 1, 79639 Grenzach-Wyhlen, Deutschland

EU/1/17/1231

21.6.2024

20.6.2024

Olanzapine Mylan

Mylan Pharmaceuticals Limited

Damastown Industrial Park, Mulhuddart, Dublin 15, DUBLIN, Ireland

EU/1/08/475

21.6.2024

20.6.2024

PANTOZOL Control

Takeda GmbH

Byk-Gulden-Straße 2, 78467 Konstanz, Deutschland

EU/1/09/517

25.6.2024

20.6.2024

SOMAC Control

Takeda GmbH

Byk-Gulden-Straße 2, 78467 Konstanz, Deutschland

EU/1/09/516

25.6.2024

20.6.2024

Spravato

Janssen-Cilag International NV

Turnhoutseweg 30, 2340 Beerse, België

EU/1/19/1410

24.6.2024

20.6.2024

Tivicay

ViiV Healthcare BV

Van Asch van Wijckstraat 55H, 3811 LP Amersfoort, Nederland

EU/1/13/892

21.6.2024

20.6.2024

TOBI Podhaler

Viatris Healthcare Limited

Damastown Industrial Park, Mulhuddart, Dublin 15, Ireland

EU/1/10/652

21.6.2024

20.6.2024

Vabysmo

Roche Registration GmbH

Emil-Barell-Strasse 1, 79639 Grenzach-Wyhlen, Deutschland

EU/1/22/1683

21.6.2024

20.6.2024

Voriconazole Accord

Accord Healthcare S.L.U.

World Trade Center, Moll de Barcelona s/n, Edifici Est, 6a planta, 08039 Barcelona, España

EU/1/13/835

21.6.2024

20.6.2024

Voriconazole Hikma

Hikma Farmacêutica (Portugal), S.A.

Estrada do Rio da Mó n.o 8, 8A e 8B, Fervença, 2705-906 Terrugem SNT, Portugal

EU/1/15/1004

28.6.2024

20.6.2024

Voxzogo

BioMarin International Limited

Shanbally, Ringaskiddy, County Cork, P43 R298, Ireland

EU/1/21/1577

24.6.2024

20.6.2024

Xaluprine

Nova Laboratories Ireland Limited

3rd Floor, Ulysses House, Foley Street, Dublin 1, Ireland

EU/1/11/727

21.6.2024

20.6.2024

Xerava

PAION Deutschland GmbH

Heussstraße 25, 52078 Aachen, Deutschland

EU/1/18/1312

24.6.2024

20.6.2024

Xtandi

Astellas Pharma Europe B.V.

Sylviusweg 62, 2333 BE Leiden, Nederland

EU/1/13/846

21.6.2024

20.6.2024

Zabdeno

Janssen-Cilag International NV

Turnhoutseweg 30, 2340 Beerse, België

EU/1/20/1444

21.6.2024

20.6.2024

Zyclara

Viatris Healthcare Limited

Damastown Industrial Park, Mulhuddart, Dublin 15, Ireland

EU/1/12/783

24.6.2024

20.6.2024

Zydelig

Gilead Sciences Ireland UC

Carrigtohill, County Cork, T45 DP77, Ireland

EU/1/14/938

21.6.2024

27.6.2024

Byetta

AstraZeneca AB

151 85 Södertälje, Sverige

EU/1/06/362

28.6.2024

27.6.2024

Levetiracetam Accord

Accord Healthcare S.L.U.

World Trade Center, Moll de Barcelona, s/n, Edifici Est 6a planta, 08039 Barcelona, España

EU/1/11/712

28.6.2024

27.6.2024

Mepact

Takeda France SAS

112 avenue Kléber, 75116 Paris, France

EU/1/08/502

2.7.2024

27.6.2024

Nucala

GlaxoSmithKline Trading Services Limited

Riverwalk 12, Citywest Business Campus, Dublin 24, Ireland

EU/1/15/1043

1.7.2024

27.6.2024

Rozlytrek

Roche Registration GmbH

Emil-Barell-Strasse 1, 79639 Grenzach-Wyhlen, Deutschland

EU/1/20/1460

28.6.2024

27.6.2024

Stribild

Gilead Sciences Ireland UC

Carrigtohill, County Cork, T45 DP77, Ireland

EU/1/13/830

28.6.2024

27.6.2024

Tavneos

Vifor Fresenius Medical Care Renal Pharma France

100-101 terrasse Boieldieu, Tour Franklin La Défense 8, 92042 Paris la Défense Cedex, France

EU/1/21/1605

28.6.2024

27.6.2024

Vokanamet

Janssen-Cilag International NV

Turnhoutseweg 30, 2340 Beerse, België

EU/1/14/918

28.6.2024

27.6.2024

Xospata

Astellas Pharma Europe B.V.

Sylviusweg 62, 2333 BE Leiden, Nederland

EU/1/19/1399

28.6.2024

27.6.2024

Zoledronic acid medac

medac Gesellschaft für klinische Spezialpräparate mbH

Theaterstraße 6, 22880 Wedel, Deutschland

EU/1/12/779

28.6.2024

28.6.2024

Cabazitaxel Accord

Accord Healthcare S.L.U.

World Trade Center, Moll de Barcelona, s/n, Edifici Est 6a planta, 08039 Barcelona, España

EU/1/20/1448

1.7.2024

28.6.2024

CRYSVITA

Kyowa Kirin Holdings B.V.

Bloemlaan 2, 2132 NP Hoofddorp, Nederland

EU/1/17/1262

2.7.2024

28.6.2024

Dovprela

Mylan IRE Healthcare Limited

Unit 35/36 Grange Parade, Baldoyle Industrial Estate, Dublin 13, Ireland

EU/1/20/1437

1.7.2024

28.6.2024

Dupixent

Sanofi Winthrop Industrie

82 avenue Raspail, 94250 Gentilly, France

EU/1/17/1229

1.7.2024

28.6.2024

Edistride

AstraZeneca AB

151 85 Södertälje, Sverige

EU/1/15/1052

1.7.2024

28.6.2024

Emtricitabine/Tenofovir disoproxil Mylan

Mylan Pharmaceuticals Limited

Damastown Industrial Park, Mulhuddart, Dublin 15, DUBLIN, Ireland

EU/1/16/1133

1.7.2024

28.6.2024

Invokana

Janssen-Cilag International NV

Turnhoutseweg 30, 2340 Beerse, België

EU/1/13/884

1.7.2024

28.6.2024

Isturisa

Recordati Rare Diseases

Immeuble Le Wilson, 70 avenue du Général de Gaulle, 92 800 Puteaux, France

EU/1/19/1407

1.7.2024

28.6.2024

Kineret

Swedish Orphan Biovitrum AB (publ)

112 76 Stockholm, Sverige

EU/1/02/203

9.7.2024

28.6.2024

Livmarli

Mirum Pharmaceuticals International B.V.

Kingsfordweg 151, 1043 GR Amsterdam, Noord-Holland, Nederland

EU/1/22/1704

1.7.2024

28.6.2024

Matever

Pharmathen S.A.

6 Dervenakion, 15351 Pallini Attiki, Ελλάδα

EU/1/11/711

3.7.2024

28.6.2024

Relvar Ellipta

GlaxoSmithKline (Ireland) Limited

12 Riverwalk, Citywest Business Campus, Dublin 24, Ireland

EU/1/13/886

1.7.2024

28.6.2024

Revinty Ellipta

GlaxoSmithKline (Ireland) Limited

12 Riverwalk, Citywest Business Campus, Dublin 24, Ireland

EU/1/14/929

1.7.2024

28.6.2024

Rotarix

GlaxoSmithKline Biologicals S.A.

rue de l'Institut 89, 1330 Rixensart, Belgique

EU/1/05/330

2.7.2024

28.6.2024

Supemtek

Sanofi Pasteur

14 Espace Henry Vallée, 69007 Lyon, France

EU/1/20/1484

1.7.2024

28.6.2024

TAGRISSO

AstraZeneca AB

151 85 Södertälje, Sverige

EU/1/16/1086

1.7.2024

28.6.2024

Zonisamide Mylan

Mylan Pharmaceuticals Limited

Damastown Industrial Park, Mulhuddart, Dublin 15, DUBLIN, Ireland

EU/1/16/1093

1.7.2024

Withdrawal of a marketing authorisation (Article 13 of Regulation (EC) No 726/2004 of the European Parliament and of the Council)

Date of the decision

Name of the medicinal product

Holder of the marketing authorisation

Number of the entry in the Community Register

Date of notification

6.6.2024

Nityr

Cycle Pharmaceuticals (Europe) Ltd

70 Sir John Rogerson's Quay, Dublin 2, D02 R296, Ireland

EU/1/18/1290

7.6.2024

10.6.2024

Lymphoseek

Navidea Biopharmaceuticals Europe Ltd.

Kilminion South, Ballinroad, Dungarvan, Co. Waterford, X35 WP70, Ireland

EU/1/14/955

13.6.2024

28.6.2024

Pemetrexed Krka

KRKA, d.d.

Novo mesto, Šmarješka cesta 6, 8501 Novo mesto, Slovenija

EU/1/18/1283

4.7.2024

Modification of a marketing authorisation (Article 38 of Regulation (EC) No 726/2004 of the European Parliament and of the Council; Article 5 of Regulation (EU) 2019/6 of the European Parliament and of the Council): Accepted

Date of the decision

Name of the medicinal product

Holder of the marketing authorisation

Number of the entry in the Community Register

Date of notification

6.6.2024

Arti-Cell Forte

Boehringer Ingelheim Vetmedica GmbH

D-55216 Ingelheim am Rhein, Deutschland

EU/2/18/228

7.6.2024

6.6.2024

Coxevac

Ceva Santé Animale

10 avenue de La Ballastière, 33500 Libourne, France

EU/2/10/110

7.6.2024

6.6.2024

Tessie

Orion Corporation

Orionintie 1, 02200 Espoo, Suomi

EU/2/21/276

7.6.2024

13.6.2024

Eurican Herpes 205

Boehringer Ingelheim Vetmedica GmbH

D-55216 Ingelheim am Rhein, Deutschland

EU/2/01/029

17.6.2024

13.6.2024

Versican Plus Pi

Zoetis Belgium

rue Laid Burniat 1, 1348 Louvain-la-Neuve, Belgique

EU/2/14/168

18.6.2024

Anyone wishing to consult the public assessment report on the medicinal products in question and the decisions relating thereto is invited to contact:

European Medicines Agency

Domenico Scarlattilaan 6

1083 HS Amsterdam

NETHERLANDS


(1)   OJ L 136, 30.4.2004, p. 1, ELI: https://data.europa.eu/eli/reg/2004/726/oj.

(2)   OJ L 4, 7.1.2019, p. 43, ELI: https://data.europa.eu/eli/reg/2019/6/oj.


ELI: http://data.europa.eu/eli/C/2024/4646/oj

ISSN 1977-091X (electronic edition)


Top